nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—MAP2K1—Corticotropin-releasing hormone—AKT1—ocular cancer	0.000709	0.000709	CbGpPWpGaD
Trametinib—MAP2K2—Integrin-mediated Cell Adhesion—AKT1—ocular cancer	0.000709	0.000709	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by Interleukins—HRAS—ocular cancer	0.000707	0.000707	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—CDKN1B—ocular cancer	0.000701	0.000701	CbGpPWpGaD
Trametinib—MAP2K2—Toll-like Receptor Signaling Pathway—AKT1—ocular cancer	0.000698	0.000698	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—CDKN1A—ocular cancer	0.000692	0.000692	CbGpPWpGaD
Trametinib—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.000688	0.000688	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000688	0.000688	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SAG—ocular cancer	0.000685	0.000685	CbGpPWpGaD
Trametinib—MAP2K2—ErbB1 downstream signaling—AKT1—ocular cancer	0.000682	0.000682	CbGpPWpGaD
Trametinib—MAP2K1—B Cell Receptor Signaling Pathway—AKT1—ocular cancer	0.00068	0.00068	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—MYC—ocular cancer	0.000675	0.000675	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—TGFB1—ocular cancer	0.000674	0.000674	CbGpPWpGaD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—TP53—ocular cancer	0.000673	0.000673	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by VEGF—HRAS—ocular cancer	0.000672	0.000672	CbGpPWpGaD
Trametinib—MAP2K2—PDGFR-beta signaling pathway—HRAS—ocular cancer	0.000672	0.000672	CbGpPWpGaD
Trametinib—MAP2K2—VEGFA-VEGFR2 Pathway—AKT1—ocular cancer	0.000672	0.000672	CbGpPWpGaD
Trametinib—MAP2K2—Disease—TFDP1—ocular cancer	0.000671	0.000671	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by Insulin receptor—HRAS—ocular cancer	0.000667	0.000667	CbGpPWpGaD
Trametinib—MAP2K1—Integrin-mediated Cell Adhesion—AKT1—ocular cancer	0.000663	0.000663	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000654	0.000654	CbGpPWpGaD
Trametinib—MAP2K1—Toll-like Receptor Signaling Pathway—AKT1—ocular cancer	0.000653	0.000653	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—CDKN1A—ocular cancer	0.000647	0.000647	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SAG—ocular cancer	0.000641	0.000641	CbGpPWpGaD
Trametinib—MAP2K1—ErbB1 downstream signaling—AKT1—ocular cancer	0.000638	0.000638	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by VEGF—AKT1—ocular cancer	0.000634	0.000634	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—MYC—ocular cancer	0.000632	0.000632	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—MDM2—ocular cancer	0.000631	0.000631	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—TGFB1—ocular cancer	0.00063	0.00063	CbGpPWpGaD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—TP53—ocular cancer	0.000629	0.000629	CbGpPWpGaD
Trametinib—MAP2K1—PDGFR-beta signaling pathway—HRAS—ocular cancer	0.000629	0.000629	CbGpPWpGaD
Trametinib—MAP2K1—VEGFA-VEGFR2 Pathway—AKT1—ocular cancer	0.000629	0.000629	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TFDP1—ocular cancer	0.000627	0.000627	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—HRAS—ocular cancer	0.00061	0.00061	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—E2F5—ocular cancer	0.000606	0.000606	CbGpPWpGaD
Trametinib—MAP2K2—BDNF signaling pathway—HRAS—ocular cancer	0.0006	0.0006	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—E2F4—ocular cancer	0.000594	0.000594	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by VEGF—AKT1—ocular cancer	0.000593	0.000593	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—MDM2—ocular cancer	0.000591	0.000591	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—HRAS—ocular cancer	0.000584	0.000584	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—RBL1—ocular cancer	0.000583	0.000583	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PSPH—ocular cancer	0.000582	0.000582	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—CDKN1B—ocular cancer	0.000577	0.000577	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—HRAS—ocular cancer	0.000575	0.000575	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—HRAS—ocular cancer	0.000571	0.000571	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00057	0.00057	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000569	0.000569	CbGpPWpGaD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—AKT1—ocular cancer	0.000568	0.000568	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—E2F5—ocular cancer	0.000567	0.000567	CbGpPWpGaD
Trametinib—MAP2K1—BDNF signaling pathway—HRAS—ocular cancer	0.000561	0.000561	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—E2F4—ocular cancer	0.000556	0.000556	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—TP53—ocular cancer	0.000555	0.000555	CbGpPWpGaD
Trametinib—MAP2K2—Insulin Signaling—HRAS—ocular cancer	0.000551	0.000551	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—GNA11—ocular cancer	0.000551	0.000551	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—CDK4—ocular cancer	0.00055	0.00055	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—HRAS—ocular cancer	0.000549	0.000549	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—HRAS—ocular cancer	0.000546	0.000546	CbGpPWpGaD
Trametinib—MAP2K2—EGF/EGFR Signaling Pathway—HRAS—ocular cancer	0.000546	0.000546	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—HRAS—ocular cancer	0.000546	0.000546	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—RBL1—ocular cancer	0.000545	0.000545	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of toll-like receptor signaling pathway—AKT1—ocular cancer	0.000545	0.000545	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—HRAS—ocular cancer	0.000543	0.000543	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—HRAS—ocular cancer	0.000541	0.000541	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—CDKN1B—ocular cancer	0.000539	0.000539	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—AKT1—ocular cancer	0.000539	0.000539	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—HRAS—ocular cancer	0.000538	0.000538	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MAML2—ocular cancer	0.000533	0.000533	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—CDKN1A—ocular cancer	0.000532	0.000532	CbGpPWpGaD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—AKT1—ocular cancer	0.000531	0.000531	CbGpPWpGaD
Trametinib—MAP2K2—BDNF signaling pathway—AKT1—ocular cancer	0.00053	0.00053	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—TP53—ocular cancer	0.000519	0.000519	CbGpPWpGaD
Trametinib—MAP2K1—Insulin Signaling—HRAS—ocular cancer	0.000516	0.000516	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—GNA11—ocular cancer	0.000515	0.000515	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—AKT1—ocular cancer	0.000515	0.000515	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—CDK4—ocular cancer	0.000515	0.000515	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—HRAS—ocular cancer	0.000513	0.000513	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—GNAQ—ocular cancer	0.000512	0.000512	CbGpPWpGaD
Trametinib—MAP2K1—EGF/EGFR Signaling Pathway—HRAS—ocular cancer	0.000511	0.000511	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—HRAS—ocular cancer	0.000511	0.000511	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—AKT1—ocular cancer	0.00051	0.00051	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—HRAS—ocular cancer	0.000509	0.000509	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	0.000509	0.000509	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—HRAS—ocular cancer	0.000509	0.000509	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—HRAS—ocular cancer	0.000508	0.000508	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—AKT1—ocular cancer	0.000507	0.000507	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—HRAS—ocular cancer	0.000506	0.000506	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—E2F3—ocular cancer	0.000505	0.000505	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—HRAS—ocular cancer	0.000504	0.000504	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—AKT1—ocular cancer	0.000504	0.000504	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—HRAS—ocular cancer	0.0005	0.0005	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MAML2—ocular cancer	0.000498	0.000498	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—CDKN1A—ocular cancer	0.000498	0.000498	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—HRAS—ocular cancer	0.000497	0.000497	CbGpPWpGaD
Trametinib—MAP2K1—BDNF signaling pathway—AKT1—ocular cancer	0.000496	0.000496	CbGpPWpGaD
Trametinib—MAP2K2—Insulin Signaling—AKT1—ocular cancer	0.000487	0.000487	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—AKT1—ocular cancer	0.000484	0.000484	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—AKT1—ocular cancer	0.000482	0.000482	CbGpPWpGaD
Trametinib—MAP2K2—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	0.000482	0.000482	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—AKT1—ocular cancer	0.000482	0.000482	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—HRAS—ocular cancer	0.000481	0.000481	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—AKT1—ocular cancer	0.00048	0.00048	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—GNAQ—ocular cancer	0.000479	0.000479	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—AKT1—ocular cancer	0.000477	0.000477	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—HRAS—ocular cancer	0.000476	0.000476	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—HRAS—ocular cancer	0.000476	0.000476	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	0.000476	0.000476	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—AKT1—ocular cancer	0.000475	0.000475	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—E2F3—ocular cancer	0.000473	0.000473	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—HRAS—ocular cancer	0.000472	0.000472	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TFDP1—ocular cancer	0.00047	0.00047	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—AKT1—ocular cancer	0.000468	0.000468	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000468	0.000468	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—HRAS—ocular cancer	0.000467	0.000467	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—HRAS—ocular cancer	0.000465	0.000465	CbGpPWpGaD
Trametinib—MAP2K1—Insulin Signaling—AKT1—ocular cancer	0.000456	0.000456	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—AKT1—ocular cancer	0.000453	0.000453	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—AKT1—ocular cancer	0.000451	0.000451	CbGpPWpGaD
Trametinib—MAP2K1—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	0.000451	0.000451	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.000451	0.000451	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—HRAS—ocular cancer	0.00045	0.00045	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—AKT1—ocular cancer	0.000449	0.000449	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	0.000449	0.000449	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—AKT1—ocular cancer	0.000449	0.000449	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—AKT1—ocular cancer	0.000449	0.000449	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—AKT1—ocular cancer	0.000447	0.000447	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—AKT1—ocular cancer	0.000445	0.000445	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—AKT1—ocular cancer	0.000441	0.000441	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TFDP1—ocular cancer	0.000439	0.000439	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—AKT1—ocular cancer	0.000439	0.000439	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—AKT1—ocular cancer	0.000438	0.000438	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.000435	0.000435	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—AKT1—ocular cancer	0.000424	0.000424	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.000421	0.000421	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—AKT1—ocular cancer	0.00042	0.00042	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—AKT1—ocular cancer	0.00042	0.00042	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	0.00042	0.00042	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—AKT1—ocular cancer	0.000416	0.000416	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—AKT1—ocular cancer	0.000413	0.000413	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—AKT1—ocular cancer	0.000411	0.000411	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.000407	0.000407	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.000398	0.000398	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—AKT1—ocular cancer	0.000397	0.000397	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000395	0.000395	CbGpPWpGaD
Trametinib—MAP2K2—Disease—HDAC1—ocular cancer	0.000389	0.000389	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MAML2—ocular cancer	0.000373	0.000373	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.000372	0.000372	CbGpPWpGaD
Trametinib—MAP2K1—Disease—HDAC1—ocular cancer	0.000364	0.000364	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—MDM2—ocular cancer	0.00036	0.00036	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—HRAS—ocular cancer	0.000352	0.000352	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CDKN2B—ocular cancer	0.000349	0.000349	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MAML2—ocular cancer	0.000349	0.000349	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—HRAS—ocular cancer	0.000347	0.000347	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—MDM2—ocular cancer	0.000337	0.000337	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—HRAS—ocular cancer	0.00033	0.00033	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CDKN1B—ocular cancer	0.000329	0.000329	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—EP300—ocular cancer	0.000327	0.000327	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CDKN2B—ocular cancer	0.000327	0.000327	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GNA11—ocular cancer	0.000325	0.000325	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—HRAS—ocular cancer	0.000324	0.000324	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—HRAS—ocular cancer	0.000314	0.000314	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PSPH—ocular cancer	0.000313	0.000313	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CDKN1B—ocular cancer	0.000308	0.000308	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—AKT1—ocular cancer	0.000306	0.000306	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—EP300—ocular cancer	0.000306	0.000306	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GNA11—ocular cancer	0.000305	0.000305	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CDKN1A—ocular cancer	0.000303	0.000303	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—GNAQ—ocular cancer	0.000303	0.000303	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—HRAS—ocular cancer	0.000293	0.000293	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—EP300—ocular cancer	0.000289	0.000289	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—AKT1—ocular cancer	0.000286	0.000286	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TGFB1—ocular cancer	0.000284	0.000284	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CDKN1A—ocular cancer	0.000284	0.000284	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—GNAQ—ocular cancer	0.000283	0.000283	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HDAC1—ocular cancer	0.000273	0.000273	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—EP300—ocular cancer	0.00027	0.00027	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TGFB1—ocular cancer	0.000266	0.000266	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HDAC1—ocular cancer	0.000255	0.000255	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CDKN2B—ocular cancer	0.000245	0.000245	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CDKN2B—ocular cancer	0.000229	0.000229	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—E2F1—ocular cancer	0.000224	0.000224	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—HRAS—ocular cancer	0.000224	0.000224	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—E2F1—ocular cancer	0.00021	0.00021	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—MDM2—ocular cancer	0.00021	0.00021	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—HRAS—ocular cancer	0.000209	0.000209	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—HRAS—ocular cancer	0.000198	0.000198	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—AKT1—ocular cancer	0.000198	0.000198	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—MDM2—ocular cancer	0.000196	0.000196	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MDM2—ocular cancer	0.000194	0.000194	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CDKN1B—ocular cancer	0.000192	0.000192	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—HRAS—ocular cancer	0.000185	0.000185	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—AKT1—ocular cancer	0.000185	0.000185	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GNA11—ocular cancer	0.000183	0.000183	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MDM2—ocular cancer	0.000181	0.000181	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CDKN1B—ocular cancer	0.000179	0.000179	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CDKN1B—ocular cancer	0.000177	0.000177	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CDKN1A—ocular cancer	0.000177	0.000177	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—AKT1—ocular cancer	0.000175	0.000175	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GNAQ—ocular cancer	0.00017	0.00017	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—EP300—ocular cancer	0.000168	0.000168	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CDKN1B—ocular cancer	0.000165	0.000165	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CDKN1A—ocular cancer	0.000165	0.000165	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—AKT1—ocular cancer	0.000163	0.000163	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CDKN1A—ocular cancer	0.000163	0.000163	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—EP300—ocular cancer	0.000157	0.000157	CbGpPWpGaD
Trametinib—MAP2K2—Disease—EP300—ocular cancer	0.000155	0.000155	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CDKN1A—ocular cancer	0.000153	0.000153	CbGpPWpGaD
Trametinib—MAP2K1—Disease—EP300—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000137	0.000137	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MDM2—ocular cancer	0.000136	0.000136	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MYC—ocular cancer	0.000135	0.000135	CbGpPWpGaD
Trametinib—MAP2K2—Disease—TGFB1—ocular cancer	0.000135	0.000135	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MDM2—ocular cancer	0.000127	0.000127	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MYC—ocular cancer	0.000127	0.000127	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TGFB1—ocular cancer	0.000126	0.000126	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HRAS—ocular cancer	0.000126	0.000126	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CDKN1B—ocular cancer	0.000124	0.000124	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCND1—ocular cancer	0.000118	0.000118	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HRAS—ocular cancer	0.000118	0.000118	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CDKN1B—ocular cancer	0.000116	0.000116	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HRAS—ocular cancer	0.000115	0.000115	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CDKN1A—ocular cancer	0.000114	0.000114	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—AKT1—ocular cancer	0.000111	0.000111	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCND1—ocular cancer	0.000111	0.000111	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—EP300—ocular cancer	0.000109	0.000109	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HRAS—ocular cancer	0.000108	0.000108	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CDKN1A—ocular cancer	0.000107	0.000107	CbGpPWpGaD
Trametinib—MAP2K2—Disease—HRAS—ocular cancer	0.000106	0.000106	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—AKT1—ocular cancer	0.000104	0.000104	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—EP300—ocular cancer	0.000102	0.000102	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—AKT1—ocular cancer	0.000102	0.000102	CbGpPWpGaD
Trametinib—MAP2K1—Disease—HRAS—ocular cancer	9.94e-05	9.94e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GNA11—ocular cancer	9.84e-05	9.84e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—AKT1—ocular cancer	9.51e-05	9.51e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MYC—ocular cancer	9.48e-05	9.48e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TGFB1—ocular cancer	9.45e-05	9.45e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—AKT1—ocular cancer	9.38e-05	9.38e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GNAQ—ocular cancer	9.14e-05	9.14e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MYC—ocular cancer	8.87e-05	8.87e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TGFB1—ocular cancer	8.84e-05	8.84e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—AKT1—ocular cancer	8.78e-05	8.78e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TP53—ocular cancer	7.78e-05	7.78e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HRAS—ocular cancer	7.44e-05	7.44e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TP53—ocular cancer	7.28e-05	7.28e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HRAS—ocular cancer	6.96e-05	6.96e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AKT1—ocular cancer	6.57e-05	6.57e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AKT1—ocular cancer	6.15e-05	6.15e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—EP300—ocular cancer	6.12e-05	6.12e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—AKT1—ocular cancer	3.7e-05	3.7e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—EP300—ocular cancer	3.29e-05	3.29e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AKT1—ocular cancer	1.99e-05	1.99e-05	CbGpPWpGaD
